Combination productDrug
Enicepatide clinical trials
Also written CT-388 and RO7795068.
- studies test it
- 9
- open now
- 6
- in phase 3
- 4
- first study started
- 2021
Keep track of what changes. Save the enicepatide studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Studies by the year they started
9 studies that test it; most in 2026 (6)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2024 | 2 |
| 2026 | 6 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 3
- Phase 3
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses enicepatide is read from its arms, and is right about nine times in ten.
Testing it · 9
- A Clinical Study to Evaluate the Effects of Enicepatide Versus Tirzepatide in Participants With Type 2 Diabetes and Inadequate Blood Sugar Control on Oral Glucose-Lowering MedicationsNot yet recruitingPhase 3Hoffmann-La RocheNCT07889648Written as Enicepatide
- A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 DiabetesRecruitingPhase 3Hoffmann-La RocheNCT07351058Written as Enicepatide
- A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 DiabetesRecruitingPhase 3Hoffmann-La RocheNCT07351045Written as Enicepatide
- A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 DiabetesRecruitingPhase 3Hoffmann-La RocheNCT07670416Written as Enicepatide
- A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Enicepatide in Generally Healthy Adult Chinese ParticipantsRecruitingPhase 1Hoffmann-La RocheNCT07626515Written as Enicepatide
- A Dose-Finding Study of Petrelintide With Enicepatide (RO7795068) in Adults With Obesity or OverweightNot yet recruitingPhase 2Hoffmann-La RocheNCT07589686Written as Enicepatide
- A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes MellitusCompletedPhase 2Carmot Therapeutics, Inc.NCT06628362Written as Enicepatide
- A Study of Enicepatide (CT-388) in Participants With Obesity or Overweight With at Least One Weight-Related ComorbidityCompletedPhase 2Carmot Therapeutics, Inc.NCT06525935Written as Enicepatide
- A Study of CT-388 in Otherwise Healthy Overweight and Obese Adults and Patients With Type 2 Diabetes MellitusCompletedPhase 1Carmot Therapeutics, Inc.NCT04838405Written as CT-388
Codes
What other systems call enicepatide · ClinicalTrials.gg INT017329
- UNII (FDA) MTP9QR7GYFENICEPATIDEOne source FDA
- NCI Thesaurus C224735EnicepatideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | MTP9QR7GYF | ENICEPATIDE | One source FDA |
| NCI Thesaurus | C224735 | Enicepatide | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.